FDA Approves New Daily Pill for Advanced Breast Cancer Resistant to Current Treatment
Source Summary
The FDA has approved a new daily pill for adults with advanced breast cancer whose tumors have developed resistance to current treatments. The approval is guided by a blood test to identify eligible patients.
Why it matters
This approval provides a new treatment option for patients with treatment-resistant advanced breast cancer, addressing a significant clinical need in oncology.
